跳至主要内容
临床试验/CTRI/2024/02/063245
CTRI/2024/02/063245招募中4 期

A Comparative Study on Assessing the Efficacy and Safety of Combination of Palmitoylethanolamide, Genistein, Diadzein )(Capsule Palmitole) as an add on therapy with Standard therapy in patients with Diabetic Neuropathy-A Randomised Open Labelled Prospective Study - NI

Government Kilpauk Medical College0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Clinically diagnosed with neuropathy using diagnostic tests (Tip-Therm test, Monofilament test, Biothesiometry) at the Diabetology Clinic in our hospital
  • Participants exhibiting neuropathic pain scoring more than 4 on Neuropathic Pain Diagnostic Questionnaire(DN4) and scoring more than 12 on S-LANSS (Self reported Leeds Assessment of Neuropathic Symptoms and Signs(S-LANSS)

排除标准

  • Participants with Type1 diabetes mellitus, not willing to participant,pregnant and lactating mothers, history of hypersensitivity,those who are on longterm steroid, those wtih documented history of other neuropathies

研究者

发起方
Government Kilpauk Medical College

相似试验